Noritoshi Sekido

Publication List Details

Period

2006 - 2007

Number

8

Co-Authors

Three-weekly Docetaxel with Prednisone is Feasible for Japanese Patients with Hormone-refractory Prostate Cancer: A Retrospective Comparative Study with Weekly Docetaxel Alone (2007)

Shimazui, Toru, Kawai, Koji, Miyanaga, Naoto, Kojima, Takahiro, Sekido, Noritoshi, Hinotsu, Shiro, ...

Background We previously reported that weekly treatment with docetaxel alone is useful for and well tolerated by patients with hormone-refractory prostate cancer (HRPC). Here, we compare it with the...

Does Tumor Size or Microvascular Invasion Affect Prognosis in Patients with Renal Cell Carcinoma? (2007)

Miyagawa, Tomoaki, Shimazui, Toru, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background We retrospectively evaluated the effects of tumor size and microvascular tumor invasion on the clinical outcomes of patients who had undergone radical nephrectomy for renal cell carcinoma...

Background Variables for the Patients with Invasive Bladder Cancer Suitable for Bladder-preserving Therapy (2007)

Miyanaga, Naoto, Akaza, Hideyuki, Hinotsu, Shiro, Joraku, Akira, Oikawa, Takehiro, Sekido, Noritoshi, ...

Objective The present study was undertaken to identify the patients suitable for bladder preservation by analysis of our data. Methods The subjects of this study were all 72 patients with T2–3N0M0...

Does Tumor Size or Microvascular Invasion Affect Prognosis in Patients with Renal Cell Carcinoma? (2007)

Miyagawa, Tomoaki, Shimazui, Toru, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background We retrospectively evaluated the effects of tumor size and microvascular tumor invasion on the clinical outcomes of patients who had undergone radical nephrectomy for renal cell carcinoma...

Treatment Outcome of Metastatic Testicular Cancer at a Single Institution in Japan, a Country with Low Incidence of Germ Cell Tumor (2006)

Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...

Background Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...

Completion and Toxicity of Induction Chemotherapy for Metastatic Testicular Cancer: An Updated Evaluation of Japanese Patients (2006)

Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...

Completion and Toxicity of Induction Chemotherapy for Metastatic Testicular Cancer: An Updated Evaluation of Japanese Patients (2006)

Kawai, Koji, Ando, Satoshi, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Miyanaga, Naoto, ...

Background: Combination of bleomycin, etoposide and cisplatin (BEP) remains the standard chemotherapy for testicular cancer. Since the development of BEP in the 1980s, there has been a considerable...

Treatment Outcome of Metastatic Testicular Cancer at a Single Institution in Japan, a Country with Low Incidence of Germ Cell Tumor (2006)

Kawai, Koji, Hinotsu, Shiro, Oikawa, Takehiro, Sekido, Noritoshi, Hattori, Kazunori, Miyanaga, Naoto, ...

Background: Incidence of testicular cancer is low in Japan. Recent investigations showed that the outcome of metastatic testicular cancer is associated with the experience of the treatment...